ACHIEVE LIFE SCIENCES INC (ACHV) Fundamental Analysis & Valuation
NASDAQ:ACHV • US0044685008
Current stock price
4.17 USD
+0.03 (+0.72%)
At close:
4.18 USD
+0.01 (+0.24%)
After Hours:
This ACHV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ACHV Profitability Analysis
1.1 Basic Checks
- In the past year ACHV has reported negative net income.
- ACHV had a negative operating cash flow in the past year.
- ACHV had negative earnings in each of the past 5 years.
- In the past 5 years ACHV always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -100.59%, ACHV is doing worse than 75.34% of the companies in the same industry.
- ACHV has a Return On Equity of -155.72%. This is in the lower half of the industry: ACHV underperforms 63.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -100.59% | ||
| ROE | -155.72% | ||
| ROIC | N/A |
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for ACHV so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ACHV Health Analysis
2.1 Basic Checks
- The number of shares outstanding for ACHV has been increased compared to 1 year ago.
- ACHV has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for ACHV has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -1.82, we must say that ACHV is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of ACHV (-1.82) is comparable to the rest of the industry.
- ACHV has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
- ACHV has a Debt to Equity ratio of 0.26. This is in the lower half of the industry: ACHV underperforms 66.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.82 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 5.14 indicates that ACHV has no problem at all paying its short term obligations.
- ACHV has a Current ratio of 5.14. This is comparable to the rest of the industry: ACHV outperforms 57.23% of its industry peers.
- ACHV has a Quick Ratio of 5.14. This indicates that ACHV is financially healthy and has no problem in meeting its short term obligations.
- ACHV has a Quick ratio (5.14) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.14 | ||
| Quick Ratio | 5.14 |
3. ACHV Growth Analysis
3.1 Past
- The earnings per share for ACHV have decreased strongly by -22.12% in the last year.
EPS 1Y (TTM)-22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, ACHV will show a very strong growth in Earnings Per Share. The EPS will grow by 28.52% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-3.94%
EPS Next 2Y3.32%
EPS Next 3Y23.61%
EPS Next 5Y28.52%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. ACHV Valuation Analysis
4.1 Price/Earnings Ratio
- ACHV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACHV. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as ACHV's earnings are expected to grow with 23.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.32%
EPS Next 3Y23.61%
5. ACHV Dividend Analysis
5.1 Amount
- ACHV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ACHV Fundamentals: All Metrics, Ratios and Statistics
4.17
+0.03 (+0.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-12 2026-03-12/amc
Earnings (Next)05-11 2026-05-11
Inst Owners46.11%
Inst Owner Change47.77%
Ins Owners4.61%
Ins Owner Change7.57%
Market Cap221.97M
Revenue(TTM)N/A
Net Income(TTM)-52.35M
Analysts81.54
Price Target15.68 (276.02%)
Short Float %13.37%
Short Ratio10.81
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.21%
Min EPS beat(2)-6.75%
Max EPS beat(2)0.34%
EPS beat(4)2
Avg EPS beat(4)-4.14%
Min EPS beat(4)-10.29%
Max EPS beat(4)0.34%
EPS beat(8)3
Avg EPS beat(8)-5.36%
EPS beat(12)6
Avg EPS beat(12)-0.04%
EPS beat(16)7
Avg EPS beat(16)-3.08%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.5%
PT rev (3m)-3.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.39%
EPS NY rev (1m)0%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 6.6 | ||
| P/tB | 6.99 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.38
EYN/A
EPS(NY)-1.15
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0
BVpS0.63
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -100.59% | ||
| ROE | -155.72% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.14 | ||
| Quick Ratio | 5.14 | ||
| Altman-Z | -1.82 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y-3.94%
EPS Next 2Y3.32%
EPS Next 3Y23.61%
EPS Next 5Y28.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-67.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-30.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.12%
OCF growth 3YN/A
OCF growth 5YN/A
ACHIEVE LIFE SCIENCES INC / ACHV Fundamental Analysis FAQ
What is the fundamental rating for ACHV stock?
ChartMill assigns a fundamental rating of 1 / 10 to ACHV.
What is the valuation status of ACHIEVE LIFE SCIENCES INC (ACHV) stock?
ChartMill assigns a valuation rating of 1 / 10 to ACHIEVE LIFE SCIENCES INC (ACHV). This can be considered as Overvalued.
What is the profitability of ACHV stock?
ACHIEVE LIFE SCIENCES INC (ACHV) has a profitability rating of 0 / 10.